Svep1 is a binding ligand of Tie1 and affects specific aspects of facial lymphatic development in a Vegfc-independent manner
eLife · 25.04.2023 · 12
DOI: 10.7554/elife.82969 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 25.04.2023. Verfasst von Melina Hußmann und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiovascular Organogenesis and Regeneration, Faculty of Medicine, WWU Münster, Münster, Germany. Hauptthemen laut MEDLINE: Zebrafish, Lymphatic Vessels. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Multiple factors are required to form functional lymphatic vessels. Here, we uncover an essential role for the secreted protein Svep1 and the transmembrane receptor Tie1 during the development of subpopulations of the zebrafish facial lymphatic network. This specific aspect of the facial network forms independently of Vascular endothelial growth factor C (Vegfc) signalling, which otherwise is the most prominent signalling axis in all other lymphatic beds. Additionally, we find that multiple specific and newly uncovered phenotypic hallmarks of svep1 mutants are also present in tie1 , but not in tie2 or vegfc mutants. These phenotypes are observed in the lymphatic vasculature of both head and trunk, as well as in the development of the dorsal longitudinal anastomotic vessel under reduced flow conditions. Therefore, our study demonstrates an important function for Tie1 signalling during lymphangiogenesis as well as blood vessel development in zebrafish. Furthermore, we show genetic interaction between svep1 and tie1 in vivo, during early steps of lymphangiogenesis, and demonstrate that zebrafish as well as human Svep1/SVEP1 protein bind to the respective Tie1/TIE1 receptors in vitro. Since compound heterozygous mutations for SVEP1 and TIE2 have recently been reported in human glaucoma patients, our data have clinical relevance in demonstrating a role for SVEP1 in TIE signalling in an in vivo setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Cardiovascular Organogenesis and Regeneration, Faculty of Medicine, WWU Münster, Münster, Germany.
- Münster Imaging Network, Cells in Motion Interfaculty Centre, Faculty of Biology, WWU Münster, Münster, Germany.
- Max Planck Institute for Heart and Lung Research, Department of Developmental Genetics, Bad Nauheim, Germany.
- Department of Cell Biology, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan.
- Münster Imaging Network, Cells in Motion Interfaculty Centre, WWU Münster, Münster, Germany.
- Institute for Dental Research and Oral Musculoskeletal Biology, Center for Biochemistry, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
ORCID-Profile: Melina Hußmann, Sarah Weischer, Claudia Carlantoni, Naoki Mochizuki, Didier Y R Stainier, Stefan Schulte-Merker
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Hußmann, M., Schulte, D., Weischer, S., Carlantoni, C., Nakajima, H., Mochizuki, N., Stainier, D. Y. R., Zobel, T., Koch, M., & Schulte-Merker, S. (2023). Svep1 is a binding ligand of Tie1 and affects specific aspects of facial lymphatic development in a Vegfc-independent manner. eLife, 12. https://doi.org/10.7554/elife.82969
Vancouver
Hußmann M, Schulte D, Weischer S, Carlantoni C, Nakajima H, Mochizuki N, et al. Svep1 is a binding ligand of Tie1 and affects specific aspects of facial lymphatic development in a Vegfc-independent manner. eLife. 2023;12. doi:10.7554/elife.82969
BibTeX
@article{Humann2023,
author = {Hußmann, Melina and Schulte, Dörte and Weischer, Sarah and Carlantoni, Claudia and Nakajima, Hiroyuki and Mochizuki, Naoki and Stainier, Didier Y R and Zobel, Thomas and Koch, Manuel and Schulte-Merker, Stefan},
title = {Svep1 is a binding ligand of Tie1 and affects specific aspects of facial lymphatic development in a Vegfc-independent manner},
journal = {eLife},
year = {2023},
volume = {12},
doi = {10.7554/elife.82969}
}
EUVIMED